The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.

This publication has 30 references indexed in Scilit:

• Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.
  Proceedings of the National Academy of Sciences, 1996
• Biochemistry and genetics of eukaryotic mismatch repair.
  Genes & Development, 1996
• Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.
  1996
• Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines.
  1995
• Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint.
  1995
• Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer
  Cell, 1995
• GTBP, a 160-Kilodalton Protein Essential for Mismatch-binding Activity in Human Cells
  Science, 1995
• Identification of mismatch repair genes and their role in the development of cancer
  Current Opinion in Genetics & Development, 1995
• Microsatellite instability: marker of a mutator phenotype in cancer.
  1994
• Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation.
  1994